In vitro activity of ceftolozane/tazobactam against Gram-negative bacilli isolated from pediatric patients: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) 2017-2021, China.

Xinli MuYing FuPengcheng LiYunsong Yu

Published in: Journal of global antimicrobial resistance (2024)

GNBs collected from paediatric patients in China showed a high susceptibility to C/T making this drug combination an effective choice for treating the paediatric population, especially those infected with P. aeruginosa.

Keyphrases

gram negative
multidrug resistant
antimicrobial resistance
intensive care unit
end stage renal disease
emergency department
ejection fraction
peritoneal dialysis
prognostic factors
drug induced